You’re on our free tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Novartis
Pharmaceuticals
Sanofi
AstraZeneca
GSK
AbbVie
Bristol Myers Squibb
Novo Nordisk
Valneva
Pfizer
Johnson and Johnson
Topics

Advertisement

Novartis

Share

Top Latest Popular

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

In re Entresto (sacubitril/valsartan) Patent Litigation (Novartis Pharms. Corp. v. MSN Labs. Private Ltd. JD Supra 20:34 Tue, 14 Apr

JD Supra 20:34 Tue, 14 Apr

Patent Law Construction (World)

Intellectual Property

Anthropic appoints Indian-origin Novartis CEO Vas Narasimhan to its board The Economic Times 17:52 Tue, 14 Apr

The Economic Times 17:52 Tue, 14 Apr

Novartis CEO joins board of "responsible" AI firm Anthropic pharmaphorum 17:18 Wed, 15 Apr

pharmaphorum 17:18 Wed, 15 Apr

Advertisement

Advertisement

Anthropic’s oversight trust just hit majority control. The tipping-point was adding Novartis CEO Vas Narasimhan to its board Drug Discovery & Development 05:05 Wed, 15 Apr

Drug Discovery & Development 05:05 Wed, 15 Apr

Anthropic Pharma

Top Internet Brands

Anthropic appoints Novartis CEO Vas Narasimhan to Board The Economic Times 16:10 Tue, 14 Apr

The Economic Times 16:10 Tue, 14 Apr

Anthropic trust appoints Novartis CEO to board crypto.news 8d

crypto.news 8d

Anthropic Crypto

Advertisement

Advertisement

Latest

In the last 4 hours

Novartis withdraws EMA application for adding new indication for Pluvicto® Novartis (Press Release) 12:17

Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA) Novartis (Press Release) 11:46

In the last 6 hours

Novartis Secures WHO Nod For Infant Malaria Therapy Coartem Baby RTT News 09:19

Earlier Today

Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants Novartis (Press Release) 06:20

Yesterday

Is It Too Late To Consider Novartis (SWX:NOVN) After A 30% One-Year Jump? Simply Wall St 22:54 Thu, 23 Apr

Unveiling Novartis (NVS) Q1 Outlook: Wall Street Estimates for Key Metrics Zacks 15:19 Thu, 23 Apr

NCCN Announces Awards for Improvement Initiatives for Chronic Myeloid Leukemia (CML) Newswise (Press Release) 14:05 Thu, 23 Apr

Wednesday

Novartis launches ‘Sjöut for Sjögren’s’ campaign, teams with Carrie Ann Inaba FiercePharma 13:56 Wed, 22 Apr

Saturday

Novartis Links AI Board Role With Access Goals And New MG Therapy Simply Wall St 06:44 Sat, 18 Apr

In the last month

Better Pharma Dividend Stock: Novartis vs. Merck The Motley Fool 20:06 Fri, 17 Apr

Advertisement

Advertisement

Advertisement

Advertisement

About our Novartis news

Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Industry Sectors Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis